Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 08-2019 | 05-2019 | 02-2019 | 11-2018 | 08-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,990 | 1,080 | 1,722 | 1,514 | 1,359 |
| Receivables | 61,402 | 69,565 | 60,390 | 53,420 | 48,660 |
| Inventories | 55,020 | 54,132 | 44,227 | 31,628 | 29,986 |
| TOTAL | $130,562 | $133,041 | $114,333 | $92,466 | $88,317 |
| Non-Current Assets | |||||
| PPE Net | 201,557 | 200,027 | 191,892 | 170,517 | 165,875 |
| Investments And Advances | 61,100 | 61,100 | 68,100 | 68,100 | 67,500 |
| Intangibles | 121,477 | 121,989 | 123,488 | 75,876 | 76,114 |
| Other Non-Current Assets | 31,441 | 2,934 | 3,770 | 4,695 | 5,095 |
| TOTAL | $415,575 | $386,050 | $387,250 | $319,188 | $314,584 |
| Total Assets | $546,137 | $519,091 | $501,583 | $411,654 | $402,901 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 80,391 | 61,791 | 53,791 | 46,940 | 43,940 |
| Accounts payable and accrued liabilities | 46,162 | 53,973 | 46,431 | 31,719 | 27,027 |
| Accrued Expenses | 7,399 | 10,687 | 7,029 | 6,824 | 4,953 |
| TOTAL | $146,831 | $137,091 | $118,943 | $97,122 | $86,827 |
| Non-Current Liabilities | |||||
| Long Term Debt | 84,748 | 87,193 | 89,637 | 34,889 | 36,125 |
| Deferred Revenues | 488 | 499 | 1,286 | 1,717 | 2,062 |
| Other Non-Current Liabilities | 31,925 | 5,270 | 1,982 | 4,774 | 5,559 |
| TOTAL | $134,359 | $111,856 | $112,576 | $60,959 | $62,693 |
| Total Liabilities | $281,190 | $248,947 | $231,519 | $158,081 | $149,520 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,152 | N/A | 29,183 | 29,170 | 27,749 |
| Common Shares | 29 | 29 | 29 | 28 | 28 |
| Retained earnings | 104,652 | 109,710 | 109,971 | 108,904 | 109,489 |
| Other shareholders' equity | -548 | 64 | 540 | 1,135 | 1,059 |
| TOTAL | $264,947 | $270,144 | $270,064 | $253,573 | $253,381 |
| Total Liabilities And Equity | $546,137 | $519,091 | $501,583 | $411,654 | $402,901 |